echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Synthetic Routes of 8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine,gadolinium deriv.

    The Synthetic Routes of 8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine,gadolinium deriv.

    • Last Update: 2023-05-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine (DNB) derivatives have been synthesized and have shown to be effective in the treatment of various diseases.
    In this article, we will discuss the synthetic routes to these derivatives, specifically in the context of the chemical industry.


    One of the most common synthetic routes to DNB derivatives involves the use of the Bischler-Napieralski reaction.
    This reaction involves the reaction of a dinitro compound with an alkyl or aryl halide in the presence of a base, such as sodium hydride.
    The resulting product is then treated with a hydrazine compound to form the DNB structure.


    Another synthetic route to DNB derivatives involves the use of the Williamson ether synthesis.
    This reaction involves the reaction of an alcohol with a diazo compound in the presence of a base, such as potassium hydroxide.
    The resulting product is then treated with a strong acid, such as hydrochloric acid, to form the DNB structure.


    In addition to these synthetic routes, DNB derivatives can also be synthesized using other methods such as the use of commercially available reagents and the use of biotechnology.
    For example, one can use a novel and efficient biotechnological method for the synthesis of DNB derivatives.
    This method is based on the action of a microorganism that possesses the ability to convert a given starting material into the desired DNB derivative.


    One of the advantages of these synthetic routes is that they allow for the large-scale production of DNB derivatives at a relatively low cost.
    This is important in the chemical industry, where the cost of production is a major factor in determining the profitability of a particular synthesis route.
    Additionally, these synthetic routes can be used to produce DNB derivatives with high purity, which is essential for their use as pharmaceuticals.


    In conclusion, there are several synthetic routes to DNB derivatives that are commonly used in the chemical industry.
    These routes include the use of the Bischler-Napieralski reaction, the Williamson ether synthesis, and the use of commercially available reagents and biotechnology.
    These routes allow for the large-scale production of DNB derivatives at a relatively low cost, and with high purity, which is essential for their use as pharmaceuticals.
    The development of new, efficient and cost-effective synthetic routes to these important pharmaceuticals will continue to be of great interest to researchers in the field of chemical synthesis.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.